CNSP
NASDAQ · Pharmaceuticals
Cns Pharmaceuticals Inc
$4.24
+0.23 (+5.74%)
Open$4.03
Previous Close$4.01
Day High$4.27
Day Low$4.03
52W High$10.54
52W Low$1.90
Volume—
Avg Volume18.9K
Market Cap6.85M
P/E Ratio—
EPS$-23.14
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+906.1% upside
Current
$4.24
$4.24
Target
$42.66
$42.66
$27.73
$42.66 avg
$55.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 401.0K | 379.4K | 323.5K |
| Net Income | 137.9K | 129.6K | 106.9K |
| Profit Margin | 34.4% | 34.2% | 33.1% |
| EBITDA | 186.8K | 161.4K | 136.4K |
| Free Cash Flow | 134.0K | 130.1K | 98.1K |
| Rev Growth | +21.3% | -7.8% | +5.5% |
| Debt/Equity | 0.24 | 0.32 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |